Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 1|pp. 389–401
The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients
Back to articleFigure 7(7 of 7)
100%
Figure 7
Figure 7.(A) The sensitivity analysis of the impact of sarcopenia on OS in TAE or TACE treated HCC patients; (B) The sensitivity analysis of the impact of SMI on OS in TAE or TACE treated HCC patients.